Education
About Us
Working with TipRanks
Follow Us
PanGenomic Health, Inc. Class A (TSE:NARA)
:NARA
Total Valuation
PanGenomic Health, Inc. Class A has a market cap or net worth of C$8.01M. The enterprise value is C$0.00.
Market CapC$8.01M
Enterprise ValueC$0.00
Share Statistics
PanGenomic Health, Inc. Class A has 14,046,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,046,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PanGenomic Health, Inc. Class A’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.05%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)0.05%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee0.00
Profits Per Employee-760.77K
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PanGenomic Health, Inc. Class A is ―. PanGenomic Health, Inc. Class A’s PEG ratio is -0.00099.
PE Ratio―
PS Ratio0.00
PB Ratio>-0.01
Price to Fair Value>-0.01
Price to FCF-0.01
Price to Operating Cash Flow-39.84
PEG Ratio-0.00099
Income Statement
In the last 12 months, PanGenomic Health, Inc. Class A had revenue of 0.00 and earned -3.80K in profits. Earnings per share was -0.82.
Revenue0.00
Gross Profit―
Operating Income-1.14K
Pretax Income-3.80K
Net Income-3.80K
EBITDA―
Earnings Per Share (EPS)-0.82
Cash Flow
In the last 12 months, operating cash flow was -1.70M and capital expenditures 9.00, giving a free cash flow of -1.70M billion.
Operating Cash Flow-1.70M
Free Cash Flow-1.70M
Free Cash Flow per Share-0.12
Dividends & Yields
PanGenomic Health, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.38
52-Week Price Change256.25%
50-Day Moving Average0.83
200-Day Moving Average1.04
Relative Strength Index (RSI)44.21
Average Volume (3m)110.39K
Important Dates
PanGenomic Health, Inc. Class A upcoming earnings date is May 5, 2026, Before Open (Confirmed).
Last Earnings DateDec 1, 2025
Next Earnings DateMay 5, 2026
Ex-Dividend Date―
Financial Position
PanGenomic Health, Inc. Class A as a current ratio of 0.02, with Debt / Equity ratio of -5.45%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.00
Net Debt to EBITDA1.18
Interest Coverage Ratio-0.02
Taxes
In the past 12 months, PanGenomic Health, Inc. Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PanGenomic Health, Inc. Class A EV to EBITDA ratio is 0.59, with an EV/FCF ratio of 0.01.
EV to Sales0.00
EV to EBITDA0.59
EV to Free Cash Flow0.01
EV to Operating Cash Flow0.01
Balance Sheet
PanGenomic Health, Inc. Class A has C$82.16K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$82.16K billion.
Cash & Marketable SecuritiesC$82.16K
Total DebtC$0.00
Net CashC$82.16K
Net Cash Per Share<C$0.01
Tangible Book Value Per Share-C$516.19
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PanGenomic Health, Inc. Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast81.01%